For those diagnosed with atrial fibrillation, hazard ratios for all-cause mortality, incident heart failure, ischemic stroke increased with higher BMI
Dietary ALA Intake Tied to Prognosis in Heart Failure
Risks for all-cause death, cardiovascular death, first heart failure hospitalization reduced with higher intake of alpha-linolenic acid
Flu, COVID-19 Vaccination Cover High Among Health Care Personnel
HCP who reported employer vaccination requirements had higher vaccination coverage for flu, COVID-19 primary series, COVID-19 booster
Genetic Study Suggests Causal Link for Vitamin D Deficiency, Mortality
L-shaped association for genetically predicted 25(OH)D with all-cause mortality, with risk decreasing up to concentration of 50 nmol/L
Risk for All-Cause Mortality No Higher With Inflammatory Bowel Disease
However, risk for cardiovascular disease, infection may be higher in some Crohn disease patients
Preeclampsia, Eclampsia Linked to Increased Offspring Mortality
Maternal hypertensive disorders of pregnancy linked to increased risks for all-cause mortality, several cause-specific mortalities in offspring from birth to young adulthood
Exercise Intervention During Chemotherapy Beneficial
Intervention during chemo linked to lower decreases in VO2peak, health-related QoL, muscle strength immediately postchemotherapy
Methamphetamines, Opiates, Cocaine, Cannabis Up Risk for A-Fib
Methamphetamine, cocaine, opiate, and cannabis exposure each associated with increased incidence of AF
Mortality Disparities by Education Widened in the U.S. in 2020
Considerable increases in disparities seen for heart disease, cancer, cerebrovascular disease, unintentional injury mortality from 2019 to 2020
Apixaban Compared to Rivaroxaban for A-Fib and Valvular Heart Disease
Risks for ischemic stroke or systemic embolism, bleeding reduced with apixaban versus rivaroxaban for atrial fibrillation and valvular heart disease